Target Healthcare REIT (LON:THRL) Hits New 1-Year High – Still a Buy?

Target Healthcare REIT (LON:THRL)’s stock price reached a new 52-week high on Tuesday . The company traded as high as GBX 107 and last traded at GBX 105.80, with a volume of 43040 shares changing hands. The stock had previously closed at GBX 105.60.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group upped their price objective on shares of Target Healthcare REIT from GBX 99 to GBX 101 and gave the company a “buy” rating in a research note on Tuesday, October 28th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and a consensus price target of GBX 101.

Target Healthcare REIT Price Performance

The stock has a market capitalization of £660.38 million, a P/E ratio of 10.85, a PEG ratio of 1.48 and a beta of 0.44. The company has a debt-to-equity ratio of 34.92, a quick ratio of 1.52 and a current ratio of 7.20. The business has a fifty day simple moving average of GBX 98.76 and a 200-day simple moving average of GBX 97.10.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.